{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:10:20Z","timestamp":1792012220258,"version":"4.4.0"},"reference-count":42,"publisher":"American Association for Cancer Research (AACR)","issue":"2","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U01CA208517"],"award-info":[{"award-number":["U01CA208517"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001784","name":"Pancreatic Cancer Action Network","doi-asserted-by":"publisher","award":["17-80-ZARE"],"award-info":[{"award-number":["17-80-ZARE"]}],"id":[{"id":"10.13039\/100001784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001784","name":"Pancreatic Cancer Action Network","doi-asserted-by":"publisher","award":["17-80-PETE"],"award-info":[{"award-number":["17-80-PETE"]}],"id":[{"id":"10.13039\/100001784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P50CA102701"],"award-info":[{"award-number":["P50CA102701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is often diagnosed too late for effective therapy. The classic strategy for early detection biomarker advancement consists of initial retrospective phases of discovery and validation with tissue samples taken from individuals diagnosed with disease, compared with controls. Using this approach, we previously reported the discovery of a blood biomarker panel consisting of thrombospondin-2 (THBS2) and CA19-9 that together could discriminate resectable stage I and IIa PDAC as well as stages III and IV PDAC, with c-statistic values in the range of 0.96 to 0.97 in two phase II studies. We now report that in two studies of blood samples prospectively collected from 1 to 15 years prior to a PDAC diagnosis (Mayo Clinic and PLCO cohorts), THBS2 and\/or CA19-9 failed to discriminate cases from healthy controls at the AUC = 0.8 needed. We conclude that PDAC progression may be heterogeneous and for some individuals can be more rapid than generally appreciated. It is important that PDAC early-detection studies incorporate high-risk, prospective prediagnostic cohorts into discovery and validation studies.<\/jats:p>\n                  <jats:p>Prevention Relevance: A blood biomarker panel of THBS2 and CA19-9 detects early stages of pancreatic ductal adenocarcinoma at diagnosis, but not when tested across a population up to 1 year earlier. Our findings suggest serial sampling over time, using prospectively collected samples for biomarker discovery, and more frequent screening of high-risk individuals.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-20-0403","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T15:35:11Z","timestamp":1602862511000},"page":"223-232","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["THBS2\/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement"],"prefix":"10.1158","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1929-8121","authenticated-orcid":false,"given":"Shirsa","family":"Udgata","sequence":"first","affiliation":[{"name":"1Institute for Regenerative Medicine, Department of Cell and Developmental Biology, Abramson Cancer Center (Tumor Biology Program), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Takenaka","sequence":"additional","affiliation":[{"name":"1Institute for Regenerative Medicine, Department of Cell and Developmental Biology, Abramson Cancer Center (Tumor Biology Program), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2903-1284","authenticated-orcid":false,"given":"William R.","family":"Bamlet","sequence":"additional","affiliation":[{"name":"2Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2539-9807","authenticated-orcid":false,"given":"Ann L.","family":"Oberg","sequence":"additional","affiliation":[{"name":"2Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3469-9775","authenticated-orcid":false,"given":"Stephanie S.","family":"Yee","sequence":"additional","affiliation":[{"name":"3Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.","family":"Carpenter","sequence":"additional","affiliation":[{"name":"3Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Herman","sequence":"additional","affiliation":[{"name":"4Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungsun","family":"Kim","sequence":"additional","affiliation":[{"name":"1Institute for Regenerative Medicine, Department of Cell and Developmental Biology, Abramson Cancer Center (Tumor Biology Program), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria M.","family":"Petersen","sequence":"additional","affiliation":[{"name":"5Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S.","family":"Zaret","sequence":"additional","affiliation":[{"name":"1Institute for Regenerative Medicine, Department of Cell and Developmental Biology, Abramson Cancer Center (Tumor Biology Program), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"2022060816491634400_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"2022060816491634400_bib2","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"2022060816491634400_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MPA.0000000000000973","article-title":"Validation of biomarkers for early detection of pancreatic cancer: summary of the Alliance of Pancreatic Cancer Consortia for biomarkers for early detection workshop","volume":"47","author":"Young","year":"2018","journal-title":"Pancreas"},{"key":"2022060816491634400_bib4","volume-title":"Cancer stat facts: pancreatic ductal adenocarcinoma (PDAC)","author":"SEER","year":"2020"},{"key":"2022060816491634400_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5583","article-title":"Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers","volume":"9","author":"Kim","year":"2017","journal-title":"Sci Transl Med"},{"key":"2022060816491634400_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pathmechdis.3.121806.154305","article-title":"Pancreatic cancer","volume":"3","author":"Maitra","year":"2008","journal-title":"Annu Rev Pathol"},{"key":"2022060816491634400_bib7","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","article-title":"A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas","volume":"39","author":"Basturk","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"2022060816491634400_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.acra.2016.12.013","article-title":"Intraductal papillary mucinous neoplasms of the pancreas: correlation of helical computed tomography (CT) features with pathologic findings","volume":"24","author":"Xu","year":"2017","journal-title":"Acad Radiol"},{"key":"2022060816491634400_bib9","first-page":"2969","article-title":"Progression model for pancreatic cancer","volume":"6","author":"Hruban","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2022060816491634400_bib10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature19823","article-title":"A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns","volume":"538","author":"Notta","year":"2016","journal-title":"Nature"},{"key":"2022060816491634400_bib11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/ng.3764","article-title":"Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer","volume":"49","author":"Makohon-Moore","year":"2017","journal-title":"Nat Genet"},{"key":"2022060816491634400_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature25459","article-title":"Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes","volume":"554","author":"Mueller","year":"2018","journal-title":"Nature"},{"key":"2022060816491634400_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/path.5194","article-title":"Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions","volume":"247","author":"Kuboki","year":"2019","journal-title":"J Pathol"},{"key":"2022060816491634400_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"2022060816491634400_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"2022060816491634400_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41588-019-0566-9","article-title":"Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution","volume":"52","author":"Chan-Seng-Yue","year":"2020","journal-title":"Nat Genet"},{"key":"2022060816491634400_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41586-018-0481-8","article-title":"Precancerous neoplastic cells can move through the pancreatic ductal system","volume":"561","author":"Makohon-Moore","year":"2018","journal-title":"Nature"},{"key":"2022060816491634400_bib18","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nature09515","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"Yachida","year":"2010","journal-title":"Nature"},{"key":"2022060816491634400_bib19","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1136\/gutjnl-2014-308653","article-title":"Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages","volume":"64","author":"Yu","year":"2015","journal-title":"Gut"},{"key":"2022060816491634400_bib20","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41379-019-0409-3","article-title":"Three-dimensional visualization of cleared human pancreas cancer reveals that sustained epithelial-to-mesenchymal transition is not required for venous invasion","volume":"33","author":"Hong","year":"2020","journal-title":"Mod Pathol"},{"key":"2022060816491634400_bib21","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.ajpath.2018.04.002","article-title":"Immunolabeling of cleared human pancreata provides insights into three-dimensional pancreatic anatomy and pathology","volume":"188","author":"No\u00eb","year":"2018","journal-title":"Am J Pathol"},{"key":"2022060816491634400_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/PAS.0b013e3182376e36","article-title":"Vascular invasion in infiltrating ductal adenocarcinoma of the pancreas can mimic pancreatic intraepithelial neoplasia: a histopathologic study of 209 cases","volume":"36","author":"Hong","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"2022060816491634400_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajpath.2018.09.013","article-title":"Current approaches to pancreatic cancer screening","volume":"189","author":"Chhoda","year":"2019","journal-title":"Am J Pathol"},{"key":"2022060816491634400_bib24","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2018.05.035","article-title":"Risk of Neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance","volume":"155","author":"Canto","year":"2018","journal-title":"Gastroenterology"},{"key":"2022060816491634400_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","article-title":"Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium","volume":"69","author":"Goggins","year":"2020","journal-title":"Gut"},{"key":"2022060816491634400_bib26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MPA.0000000000000368","article-title":"Early detection of sporadic pancreatic cancer: summative review","volume":"44","author":"Chari","year":"2015","journal-title":"Pancreas"},{"key":"2022060816491634400_bib27","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.celrep.2013.05.036","article-title":"An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression","volume":"3","author":"Kim","year":"2013","journal-title":"Cell Rep"},{"key":"2022060816491634400_bib28","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","article-title":"Phases of biomarker development for early detection of cancer","volume":"93","author":"Pepe","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"2022060816491634400_bib29","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jnci\/djn326","article-title":"Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design","volume":"100","author":"Pepe","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2022060816491634400_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jso.2930290106","article-title":"A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma","volume":"29","author":"Satake","year":"1985","journal-title":"J Surg Oncol"},{"key":"2022060816491634400_bib31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/annonc\/mdp332","article-title":"Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report","volume":"21","author":"Duffy","year":"2010","journal-title":"Ann Oncol"},{"key":"2022060816491634400_bib32","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1200\/JCO.2006.08.2644","article-title":"ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer","volume":"24","author":"Locker","year":"2006","journal-title":"J Clin Oncol"},{"key":"2022060816491634400_bib33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejso.2006.10.004","article-title":"Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer","volume":"33","author":"Goonetilleke","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"2022060816491634400_bib34","first-page":"5501","article-title":"Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer","volume":"47","author":"Tempero","year":"1987","journal-title":"Cancer Res"},{"key":"2022060816491634400_bib35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.hoc.2015.04.007","article-title":"Familial pancreatic adenocarcinoma","volume":"29","author":"Petersen","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"2022060816491634400_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.228452.113","article-title":"Familial pancreatic cancer: genetic advances","volume":"28","author":"Rustgi","year":"2014","journal-title":"Genes Dev"},{"key":"2022060816491634400_bib37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/cncr.21166","article-title":"Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma","volume":"104","author":"McWilliams","year":"2005","journal-title":"Cancer"},{"key":"2022060816491634400_bib38","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0272989X18801312","article-title":"A tutorial on evaluating the time-varying discrimination accuracy of survival models used in dynamic decision making","volume":"38","author":"Bansal","year":"2018","journal-title":"Med Decis Making"},{"key":"2022060816491634400_bib39","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1158\/1078-0432.CCR-14-0365","article-title":"Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection","volume":"21","author":"O'Brien","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2022060816491634400_bib40","doi-asserted-by":"crossref","first-page":"273s","DOI":"10.1016\/S0197-2456(00)00098-2","article-title":"Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial","volume":"21","author":"Prorok","year":"2000","journal-title":"Control Clin Trials"},{"key":"2022060816491634400_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cyto.2017.02.016","article-title":"Impact of freeze-thaw cycles on circulating inflammation marker measurements","volume":"95","author":"Huang","year":"2017","journal-title":"Cytokine"},{"key":"2022060816491634400_bib42","doi-asserted-by":"crossref","first-page":"e94928","DOI":"10.1371\/journal.pone.0094928","article-title":"Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study","volume":"9","author":"Nolen","year":"2014","journal-title":"PLoS One"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/14\/2\/223\/3040687\/223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/14\/2\/223\/3040687\/223.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T15:13:06Z","timestamp":1654701186000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/14\/2\/223\/276660\/THBS2-CA19-9-Detecting-Pancreatic-Ductal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,5]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-20-0403","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.22533953.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22533950","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6547325.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22533953","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6547325","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22533950.v1","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}